Lindbrook Capital »

Silverback Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.2k 700 10.22
2023-12-31 $3.8k 700 5.48
2023-09-30 $789 209 3.78
2023-06-30 $0 0 0.00